FR2406999A1 - Stabilisant pour polysaccharides de meningocoques - Google Patents

Stabilisant pour polysaccharides de meningocoques

Info

Publication number
FR2406999A1
FR2406999A1 FR7830616A FR7830616A FR2406999A1 FR 2406999 A1 FR2406999 A1 FR 2406999A1 FR 7830616 A FR7830616 A FR 7830616A FR 7830616 A FR7830616 A FR 7830616A FR 2406999 A1 FR2406999 A1 FR 2406999A1
Authority
FR
France
Prior art keywords
stabilizer
meningococcal polysaccharides
lactose
addition
meningococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7830616A
Other languages
English (en)
Other versions
FR2406999B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of FR2406999A1 publication Critical patent/FR2406999A1/fr
Application granted granted Critical
Publication of FR2406999B1 publication Critical patent/FR2406999B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

POUR AMELIORER LA STABILITE DE POLYSACCHARIDES DE MENINGOCOQUES EN SOLUTION AQUEUSE, L'ADDITION CONNUE DE LACTOSE EST REMPLACEE TOTALEMENT OU PARTIELLEMENT PAR L'ADDITION D'UN AUTRE COMPOSE FORMATEUR D'HYDRATE QUI PEUT ETRE DESHYDRATE DE MANIERE REVERSIBLE DANS LES CONDITIONS DE LYOPHYLISATION. ON PEUT ENSUITE SECHER LE MELANGE ETOU LE CONFECTIONNER EN UN VACCIN. LE COMPOSE EST, PAR EXEMPLE, LE SACCHAROSE, LE RAFFINOSE, LE GLUCOSE, LE TREHALOSE, UN GLYCEROPHOSPHATE OU UN GLUTAMINATE.
FR7830616A 1977-10-27 1978-10-27 Stabilisant pour polysaccharides de meningocoques Granted FR2406999A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772748132 DE2748132A1 (de) 1977-10-27 1977-10-27 Stabilisator fuer polysaccharid

Publications (2)

Publication Number Publication Date
FR2406999A1 true FR2406999A1 (fr) 1979-05-25
FR2406999B1 FR2406999B1 (fr) 1982-11-12

Family

ID=6022367

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7830616A Granted FR2406999A1 (fr) 1977-10-27 1978-10-27 Stabilisant pour polysaccharides de meningocoques

Country Status (11)

Country Link
US (1) US4206200A (fr)
JP (1) JPS5470422A (fr)
BE (1) BE871612A (fr)
CA (1) CA1113861A (fr)
DE (1) DE2748132A1 (fr)
DK (1) DK158006C (fr)
ES (1) ES474412A1 (fr)
FI (1) FI61807B (fr)
FR (1) FR2406999A1 (fr)
GB (1) GB2009198B (fr)
SE (1) SE447700B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072513A2 (fr) * 1981-08-14 1983-02-23 Smithkline Biologicals S.A. Procédé de préparation de polysaccharides bactériens capsulaires antigéniques purifiés, produits obtenus et leur utilisation
WO1987000196A1 (fr) * 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection des proteines et similaires
GB2187191A (en) * 1984-01-30 1987-09-03 Quadrant Bioresources Ltd Protection of proteins and the like

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
US4868108A (en) * 1985-12-12 1989-09-19 Hygeia Sciences, Incorporated Multiple-antibody detection of antigen
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
JPH03208485A (ja) * 1990-01-11 1991-09-11 Matsushita Electric Ind Co Ltd 文字放送受信装置
US5200399A (en) * 1990-09-14 1993-04-06 Boyce Thompson Institute For Plant Research, Inc. Method of protecting biological materials from destructive reactions in the dry state
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US7448375B2 (en) * 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US6024090A (en) * 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
ES2218543T3 (es) * 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
DE69530196T2 (de) 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
GB9508691D0 (en) 1995-04-28 1995-06-14 Pafra Ltd Stable compositions
US5876992A (en) 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CA2464308A1 (fr) 2001-10-22 2003-05-01 Dompe S.P.A. Traitement de fluides supercritiques : preparation de microparticules de proteines et leur stabilisation
EP1490409B1 (fr) * 2002-03-26 2008-12-31 Novartis Vaccines and Diagnostics S.r.l. Saccharides modifies presentant une stabilite amelioree dans l'eau
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
GT200600112A (es) 2005-03-14 2006-11-29 Composiciiones de tigeciclina y metodos de preparacion
CA2611960C (fr) * 2005-06-27 2015-05-05 Glaxosmithkline Biologicals S.A. Compositions immunogeniques comprenant des conjugues de saccharides capsulaires n.meningitidis
GB0612854D0 (en) * 2006-06-28 2006-08-09 Novartis Ag Saccharide analysis
CN102803483B (zh) 2009-06-12 2014-04-30 精密公司 用于微流体装置中taq 聚合酶的干燥储存的可再水合基质
WO2010144683A2 (fr) 2009-06-12 2010-12-16 Micronics, Inc. Compositions et procédés pour le stockage à l'état déshydraté de réactifs sur puce dans des dispositifs microfluidiques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB995362A (en) * 1962-05-11 1965-06-16 Smith Kline French Lab Improvements in or relating to freeze-drying biological material
FR1588829A (fr) * 1967-06-22 1970-03-16

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2908614A (en) * 1954-08-10 1959-10-13 Glaxo Lab Ltd Use of dextran in freeze-drying process
US3135663A (en) * 1960-06-28 1964-06-02 Glaxo Group Ltd Vaccines
DE1183629B (de) * 1962-12-21 1964-12-17 Behringwerke Ag Verfahren zur Stabilisierung biologisch aktiven Materials
US3567585A (en) * 1963-07-12 1971-03-02 Ciba Geigy Corp Process for obtaining bcg-cultures
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
FR7461M (fr) * 1968-06-19 1970-01-05
GB1218277A (en) * 1968-08-20 1971-01-06 Miles Lab Dry water-dispersible aluminium hydroxide gels
US3577527A (en) * 1969-01-27 1971-05-04 Us Navy Neisseria meningitidis antigen
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
US3859434A (en) * 1973-01-08 1975-01-07 Canadian Patents Dev Meningococcal antigens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB995362A (en) * 1962-05-11 1965-06-16 Smith Kline French Lab Improvements in or relating to freeze-drying biological material
FR1588829A (fr) * 1967-06-22 1970-03-16

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1977 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072513A2 (fr) * 1981-08-14 1983-02-23 Smithkline Biologicals S.A. Procédé de préparation de polysaccharides bactériens capsulaires antigéniques purifiés, produits obtenus et leur utilisation
EP0072513A3 (en) * 1981-08-14 1986-02-19 Smith Kline - Rit Societe Anonyme Dite: Process for the preparation of purified bacterial capsular antigenic polysaccharides, the obtained products and their use
GB2187191A (en) * 1984-01-30 1987-09-03 Quadrant Bioresources Ltd Protection of proteins and the like
GB2187191B (en) * 1984-01-30 1989-11-01 Quadrant Bioresources Ltd Protection of proteins and the like
WO1987000196A1 (fr) * 1985-07-09 1987-01-15 Quadrant Bioresources Limited Protection des proteines et similaires

Also Published As

Publication number Publication date
DE2748132C2 (fr) 1989-04-06
GB2009198A (en) 1979-06-13
DK158006B (da) 1990-03-12
FI61807B (fi) 1982-06-30
GB2009198B (en) 1982-10-27
SE447700B (sv) 1986-12-08
FR2406999B1 (fr) 1982-11-12
US4206200A (en) 1980-06-03
SE7811083L (sv) 1979-04-28
JPS5470422A (en) 1979-06-06
JPS6310686B2 (fr) 1988-03-08
DK477278A (da) 1979-04-28
DK158006C (da) 1990-08-06
CA1113861A (fr) 1981-12-08
ES474412A1 (es) 1979-04-16
BE871612A (fr) 1979-04-27
DE2748132A1 (de) 1979-05-03
FI783250A (fi) 1979-04-28

Similar Documents

Publication Publication Date Title
FR2406999A1 (fr) Stabilisant pour polysaccharides de meningocoques
DK3891A (da) Stabiliseret enzymdispersion
SU513645A3 (ru) Реактив дл определени глюкозы
ES8505545A1 (es) Un procedimiento para producir un preparado de gamma-interferon estable
GB1437432A (en) Selfneutralizing well acidizing
GB1417003A (en) Stabilisation of fibrinogen
NO145380C (no) Prostansyrederivat for anvendelse som svangerskapsforebyggende middel, som svangerskaps-avbrytende middel, for regulering av den oestrale periode og som tilsetning til saed ved inseminasjon
ES8400417A1 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
KR920008058A (ko) 고체 락툴로스
SU464087A3 (ru) Способ получени суспензии гонадотропинов
DE3860920D1 (de) Hydraulischer zement.
GB977933A (en) Thick web dendritic growth
IE791875L (en) Sodium amoxicillin preparations
IE34609L (en) Therapeutic substituted thiazolidinedione
GB1465645A (fr)
FR2187312A1 (en) Rapidly-soluble paracetamol - prepd by recrystallization from aqueous dioxan
EP0048194A3 (fr) Procédé de lyophilisation
Koff Age, Experience, and Success Among Women Managers.
SU464597A1 (ru) Способ получени аминолигнина
GB1389859A (en) Salts of fluorinated amino acid with optically active acids or bases
USD222179S (en) Fish skinner
ATE80296T1 (de) Antineoplastische formulierungen.
SU461777A1 (ru) Способ штамповки профилей с продольными и поперечными элементами жесткости
SU507582A1 (ru) Способ получени ацетилхолинэстеразы
GB1498295A (en) Treatment of dehydration in veterinary medicine

Legal Events

Date Code Title Description
TP Transmission of property